OT - Drug Rep Fired, Sexually Assaulted for Refusing to Promote Off-Label Use of Drugs, Lawsuit Alleges

[Guest guest]

http://snipurl.com/80s1v  [www_naturalnews_com] Drug Rep Fired, Sexually Assaulted for Refusing to Promote Off-Label Use of Drugs, Lawsuit Allegesby Mike , the Health Ranger, December 11, 2008A former Roche drug rep, Carolyn Gleason, claims to have been sexually assaulted and fired for refusing to promote drugs for off-label uses. She was tasked with selling the drug Mycamine in northern Florida. When sales were poor, her sales manager requested she start pushing the drug for off-label use, she alleges."Off-label" use refers to the practice of doctors prescribing drugs for health conditions they were never approved for by the FDA. Off-label prescribing of drugs is frighteningly common in conventional medicine, making a mockery of the very idea that drugs are proven "safe and effective" before being prescribed to patients.In reality, many drugs aren't even tested in the patient groups (children, for example) before being widely prescribed to them in an off-label context.That may be why this drug rep refused to promote drugs for off-label use. She alleges that she was ordered to market the drug for "all purposes," recommending dosages that were never approved by the FDA.Much of conventional medicine is based on scientific fraud, including the widespread off-label application of drugs. What this allows Big Pharma to do is get the drug approved for one condition (like nail fungus) and then sell the drug to doctors, urging them (wink! wink!) to prescribe the drug for something like, say, mental disorders.The very fact that this practice is so widely tolerated in conventional medicine is yet another demonstration of the deeply-rooted fraud that now permeates the pharmaceutical industry.Click to read:Drug Rep Fired, Sexually Assaulted for Refusing to Promote Off-Label Use of Drugs, Lawsuit AllegesFrom Pharmalot.com: In her lawsuit, Gleason charges she was sexually harassed and, eventually, fired because she refused to follow orders to market the drug for “all purposes,” such as telling docs the drug could be used in lower-cost, 100mg doses to treat candidemia. The FDA, though, had not approved Mycamine for that use or dosage. As an example, she cites a June 2007 club luncheon at which a presentation was being made and she refused her supervisor’s instructions to discuss an unapproved clinical study article.... more===== =====In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes.

[Guest guest]

http://snipurl.com/80s1v  [www_naturalnews_com] Drug Rep Fired, Sexually Assaulted for Refusing to Promote Off-Label Use of Drugs, Lawsuit Allegesby Mike , the Health Ranger, December 11, 2008A former Roche drug rep, Carolyn Gleason, claims to have been sexually assaulted and fired for refusing to promote drugs for off-label uses. She was tasked with selling the drug Mycamine in northern Florida. When sales were poor, her sales manager requested she start pushing the drug for off-label use, she alleges."Off-label" use refers to the practice of doctors prescribing drugs for health conditions they were never approved for by the FDA. Off-label prescribing of drugs is frighteningly common in conventional medicine, making a mockery of the very idea that drugs are proven "safe and effective" before being prescribed to patients.In reality, many drugs aren't even tested in the patient groups (children, for example) before being widely prescribed to them in an off-label context.That may be why this drug rep refused to promote drugs for off-label use. She alleges that she was ordered to market the drug for "all purposes," recommending dosages that were never approved by the FDA.Much of conventional medicine is based on scientific fraud, including the widespread off-label application of drugs. What this allows Big Pharma to do is get the drug approved for one condition (like nail fungus) and then sell the drug to doctors, urging them (wink! wink!) to prescribe the drug for something like, say, mental disorders.The very fact that this practice is so widely tolerated in conventional medicine is yet another demonstration of the deeply-rooted fraud that now permeates the pharmaceutical industry.Click to read:Drug Rep Fired, Sexually Assaulted for Refusing to Promote Off-Label Use of Drugs, Lawsuit AllegesFrom Pharmalot.com: In her lawsuit, Gleason charges she was sexually harassed and, eventually, fired because she refused to follow orders to market the drug for “all purposes,” such as telling docs the drug could be used in lower-cost, 100mg doses to treat candidemia. The FDA, though, had not approved Mycamine for that use or dosage. As an example, she cites a June 2007 club luncheon at which a presentation was being made and she refused her supervisor’s instructions to discuss an unapproved clinical study article.... more===== =====In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes.